302 related articles for article (PubMed ID: 29760406)
1. LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling.
Tang J; Li Y; Sang Y; Yu B; Lv D; Zhang W; Feng H
Oncogene; 2018 Aug; 37(34):4723-4734. PubMed ID: 29760406
[TBL] [Abstract][Full Text] [Related]
2. Effect of lncRNA PVT1/miR186/KLF5 Axis on the Occurrence and Progression of Cholangiocarcinoma.
Sun Q; Gong X; Wu J; Hu Z; Zhang Q; Gong J; Zhu X
Biomed Res Int; 2021; 2021():8893652. PubMed ID: 34337058
[TBL] [Abstract][Full Text] [Related]
3. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.
Huang TT; Tseng LM; Chen JL; Chu PY; Lee CH; Huang CT; Wang WL; Lau KY; Tseng MF; Chang YY; Chiang TY; Ueng YF; Lee HC; Dai MS; Liu CY
EBioMedicine; 2020 Apr; 54():102717. PubMed ID: 32268268
[TBL] [Abstract][Full Text] [Related]
4. PVT1 affects EMT and cell proliferation and migration via regulating p21 in triple-negative breast cancer cells cultured with mature adipogenic medium.
Wang L; Wang R; Ye Z; Wang Y; Li X; Chen W; Zhang M; Cai C
Acta Biochim Biophys Sin (Shanghai); 2018 Dec; 50(12):1211-1218. PubMed ID: 30371726
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
[TBL] [Abstract][Full Text] [Related]
6. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
Han C; Li X; Fan Q; Liu G; Yin J
Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
[TBL] [Abstract][Full Text] [Related]
7. miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.
Zhou W; Song F; Wu Q; Liu R; Wang L; Liu C; Peng Y; Mao S; Feng J; Chen C
PLoS One; 2017; 12(4):e0176395. PubMed ID: 28437471
[TBL] [Abstract][Full Text] [Related]
8. LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA.
Tang J; Zhong G; Zhang H; Yu B; Wei F; Luo L; Kang Y; Wu J; Jiang J; Li Y; Wu S; Jia Y; Liang X; Bi A
Cell Death Dis; 2018 Dec; 9(12):1167. PubMed ID: 30518934
[TBL] [Abstract][Full Text] [Related]
9. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
Zhao J; Du P; Cui P; Qin Y; Hu C; Wu J; Zhou Z; Zhang W; Qin L; Huang G
Oncogene; 2018 Jul; 37(30):4094-4109. PubMed ID: 29706652
[TBL] [Abstract][Full Text] [Related]
10. DANCR Induces Cisplatin Resistance of Triple-Negative Breast Cancer by KLF5/p27 Signaling.
Su A; Yao K; Zhang H; Wang Y; Zhang H; Tang J
Am J Pathol; 2023 Mar; 193(3):248-258. PubMed ID: 36509121
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA THOR Enhances the Stem Cell-Like Traits of Triple-Negative Breast Cancer Cells Through Activating β-Catenin Signaling.
Wang B; Ye Q; Zou C
Med Sci Monit; 2020 Jul; 26():e923507. PubMed ID: 32665537
[TBL] [Abstract][Full Text] [Related]
12. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Wu H; Marcus A; Leyland-Jones B; Dey N
Oncotarget; 2016 Jul; 7(28):43124-43149. PubMed ID: 27281609
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
Vishnubalaji R; Alajez NM
Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
Zuo Y; Li Y; Zhou Z; Ma M; Fu K
Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
[TBL] [Abstract][Full Text] [Related]
15. LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer.
Luo L; Tang H; Ling L; Li N; Jia X; Zhang Z; Wang X; Shi L; Yin J; Qiu N; Liu H; Song Y; Luo K; Li H; He Z; Zheng G; Xie X
Oncogene; 2018 Nov; 37(47):6166-6179. PubMed ID: 30002443
[TBL] [Abstract][Full Text] [Related]
16. Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1.
Liu R; Zhi X; Zhou Z; Zhang H; Yang R; Zou T; Chen C
Sci Rep; 2018 Jan; 8(1):1138. PubMed ID: 29348684
[TBL] [Abstract][Full Text] [Related]
17. Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling.
Liu L; Yu D; Shi H; Li J; Meng L
Pharmazie; 2017 Oct; 72(10):599-603. PubMed ID: 29441885
[TBL] [Abstract][Full Text] [Related]
18. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.
Shen H; Yan W; Yuan J; Wang Z; Wang C
J Exp Clin Cancer Res; 2019 Jun; 38(1):243. PubMed ID: 31174562
[TBL] [Abstract][Full Text] [Related]
19. LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other.
Liu AN; Qu HJ; Gong WJ; Xiang JY; Yang MM; Zhang W
J Cell Biochem; 2019 Sep; 120(9):14860-14866. PubMed ID: 31033015
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19.
Wang N; Hou M; Zhan Y; Sheng X
J Cell Biochem; 2019 Sep; 120(9):15083-15088. PubMed ID: 31026090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
